Millennium Management’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-236,400
Closed -$395K – 6469
2023
Q4
$395K Buy
+236,400
New +$642K ﹤0.01% 4790
2023
Q1
– Sell
-200,000
Closed -$792K – 6660
2022
Q4
$792K Buy
200,000
+133,400
+200% +$702K ﹤0.01% 4385
2022
Q3
$612K Buy
+66,600
New +$505K ﹤0.01% 4779
2021
Q1
– Sell
-20,000
Closed -$134K – 6289
2020
Q4
$134K Buy
+20,000
New +$134K ﹤0.01% 4965

Other funds holding MIST

Millennium Management's MIST Position: Q3 2026 in Review

Millennium Management reduced its Milestone Pharmaceuticals (MIST) stake by 29% in Q3 2026, selling an estimated $1.01M and leaving 2,235,274 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3947.

Millennium Management first reported a position in MIST in Q2 2019 and has held it in 28 quarters since. The position peaked at $8.58M in Q3 2022. 74 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

  • Millennium Management held 2,235,274 shares of Milestone Pharmaceuticals worth $1.94M as of Q3 2026.
  • Millennium Management sold 906,945 Milestone Pharmaceuticals shares in Q3 2026, an estimated $1.01M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3947 holding.
  • Millennium Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • Millennium Management's Milestone Pharmaceuticals position peaked at $8.58M in Q3 2022.
  • 74 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.